a public good project by the
Synthesis
Company
of California

© 2026

Pilar Martín‐Dávila | doi.page

0 works0 citations0 h-index

Pilar Martín‐Dávila

Universidad de Alcalá(ES)Instituto Cajal(ES)Instituto de Salud Carlos III(ES)Centro de Investigación Biomédica en Red(ES)Instituto Ramón y Cajal de Investigación Sanitaria(ES)Hospital Universitario Ramón y Cajal(ES)

Publications by Year

Research Areas

Infective Endocarditis Diagnosis and Management, Antifungal resistance and susceptibility, Cytomegalovirus and herpesvirus research, Pneumocystis jirovecii pneumonia detection and treatment, Antibiotic Resistance in Bacteria

Most-Cited Works

→ Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort(2020)396 cited
→ Zygomycosis in Solid Organ Transplant Recipients: A Prospective, Matched Case‐Control Study to Assess Risks for Disease and Outcome(2009)237 cited
→ Linezolid for the treatment of multidrug-resistant tuberculosis(2005)224 cited
→ Transmission of Tropical and Geographically Restricted Infections during Solid-Organ Transplantation(2008)196 cited
→ Risk factors for invasive aspergillosis in liver transplant recipients(2002)186 cited
→ Ca-125: A Useful Marker to Distinguish Pulmonary Tuberculosis from Other Pulmonary Infections(2009)174 cited

→ Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations(2017)

147 cited

→ Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients(2017)147 cited

→ Risk Factors, Clinical Features, and Outcomes of Toxoplasmosis in Solid-Organ Transplant Recipients: A Matched Case-Control Study(2011)144 cited

→ Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation size(2005)132 cited